Allergan, Inc. (AGN)

Slide schematic 8/8

callout 4/4 chart 1/1 disclaimer 1/1 title 2/2

Components 8

primary primary primary primary line disclaimer action-title headline

Tools 1

An investment in Valeant shares on the day Mike Pearson became CEO has appreciated 25x in six years including dividend reinvestment

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 1

before-after-framing 90%

Shows performance before and after CEO appointment and specific acquisitions.

Find anything